High expression of CCL20 in HNSCC was associated with poorer overall survival (OS) (Figure 1I), and in NPC, it was associated with a trend toward reduced progression-free survival (PFS), though the result did not reach statistical significance (Figure 1J). Here, CCL20 is linked to nasopharyngeal carcinoma.